National Planning Corporation’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-63,100
| Closed | -$3.66M | – | 637 |
|
|
2017
Q3 | $3.66M | Buy |
63,100
+10,905
| +21% | +$633K | 0.31% | 69 |
|
|
2017
Q2 | $6.38M | Sell |
52,195
-205
| -0.4% | -$25.1K | 0.49% | 42 |
|
|
2017
Q1 | $5.89M | Sell |
52,400
-320
| -0.6% | -$36K | 0.45% | 50 |
|
|
2016
Q4 | $5.68M | Buy |
52,720
+210
| +0.4% | +$22.6K | 0.44% | 47 |
|
|
2016
Q3 | $5.29M | Buy |
52,510
+1,675
| +3% | +$169K | 0.42% | 52 |
|
|
2016
Q2 | $8.67M | Buy |
50,835
+325
| +0.6% | +$55.4K | 0.67% | 26 |
|
|
2016
Q1 | $6.74M | Buy |
50,510
+24,305
| +93% | +$3.24M | 0.59% | 32 |
|
|
2015
Q4 | $2.58M | Buy |
26,205
+625
| +2% | +$61.6K | 0.21% | 106 |
|
|
2015
Q3 | $4.73M | Buy |
25,580
+225
| +0.9% | +$41.6K | 0.43% | 53 |
|
|
2015
Q2 | $6.01M | Buy |
25,355
+2,350
| +10% | +$557K | 0.54% | 35 |
|
|
2015
Q1 | $5.93M | Buy |
23,005
+22,880
| +18,304% | +$5.9M | 0.53% | 40 |
|
|
2014
Q4 | $19.7K | Buy |
+125
| New | +$19.7K | ﹤0.01% | 1731 |
|